HomeAI · summaries
Storia in 12 fonti
US approves Gilead’s twice-yearly shot for HIV prevention
Lenacapavir was nearly 100 per cent effective in preventing HIV in clinical trials.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
usatoday.com
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
- ·
nytimes.com
Regulators Approve Lenacapavir for H.I.V. Prevention
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
